You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康德萊(603987.SH):H股子公司部分境內未上市股份申請“全流通”事項獲聯交所批准上市
格隆匯 09-07 19:44

格隆匯9月7日丨康德萊(603987.SH)公佈,經向中國證監會提出H股全流通申請,康德萊醫械於2021年8月19日收到了中國證監會下發的《關於核准上海康德萊醫療器械股份有限公司部分境內未上市股份到境外上市的批覆》(證監許可【2021】2680號),核准公司所持有的康德萊醫械境內未上市股份42,857,142股全部轉換為境外上市股份,相關股份完成轉換後可在香港聯交所上市,批覆自核準之日起12個月有效。

收到上述核准批覆後,康德萊醫械根據有關規定辦理本次股份轉換涉及的各項工作。經向香港聯交所上市委員會申請,康德萊醫械於2021年9月7日獲得香港聯交所出具的上市批准,核准公司持有的42,857,142股H股上市及買賣。

上述股份轉換及上市事宜已完成在中國證券登記結算有限責任公司深圳分公司辦理的內資股註銷登記程序。公司預計公司所持有的4285.71萬股H股將於2021年9月10日完成H股轉登記業務並存入香港中央結算有限公司運作的中央結算系統,並於2021年9月13日上午9時開始在香港聯交所上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account